Sign In
Buy PMCB
$0.751
-0.0489 (-6.11%)
At Close: Jun 02, 2026
Pharmacyt Biotch Earnings Calls
Apr 30, 2026
(Upcoming)
| Release date | Jul 01, 2026 |
| EPS estimate | -$0.0600 |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
| Expected change | +/- 6.97% |
Jan 31, 2026
$0.130 (316.67%)
| Release date | Mar 17, 2026 |
| EPS estimate | -$0.0600 |
| EPS actual | $0.130 |
| EPS Surprise | 316.67% |
| Revenue estimate | - |
| Revenue actual | - |
Oct 31, 2025
| Release date | Dec 18, 2025 |
| EPS estimate | - |
| EPS actual | -$0.320 |
| Revenue estimate | - |
| Revenue actual | - |
Jul 31, 2025
| Release date | Sep 15, 2025 |
| EPS estimate | - |
| EPS actual | -$0.0900 |
| Revenue estimate | - |
| Revenue actual | - |
Last 4 Quarters for Pharmacyt Biotch
Below you can see how PMCB performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
Jul 31, 2025
| Release date | Sep 15, 2025 |
| Price on release | $1.03 |
| EPS estimate | - |
| EPS actual | -$0.0900 |
| Date | Price |
|---|---|
| Sep 09, 2025 | $1.07 |
| Sep 10, 2025 | $1.01 |
| Sep 11, 2025 | $1.03 |
| Sep 12, 2025 | $1.04 |
| Sep 15, 2025 | $1.03 |
| Sep 16, 2025 | $1.01 |
| Sep 17, 2025 | $0.93 |
| Sep 18, 2025 | $0.97 |
| Sep 19, 2025 | $0.98 |
| 4 days before | -3.47% |
| 4 days after | -4.85% |
| On release day | -1.94% |
| Change in period | -8.15% |
Oct 31, 2025
| Release date | Dec 18, 2025 |
| Price on release | $0.84 |
| EPS estimate | - |
| EPS actual | -$0.320 |
| Date | Price |
|---|---|
| Dec 12, 2025 | $1.02 |
| Dec 15, 2025 | $0.94 |
| Dec 16, 2025 | $0.95 |
| Dec 17, 2025 | $0.82 |
| Dec 18, 2025 | $0.84 |
| Dec 19, 2025 | $0.86 |
| Dec 22, 2025 | $0.84 |
| Dec 23, 2025 | $0.770 |
| Dec 24, 2025 | $0.765 |
| 4 days before | -17.64% |
| 4 days after | -8.94% |
| On release day | 2.08% |
| Change in period | -25.00% |
Jan 31, 2026
Beat
| Release date | Mar 17, 2026 |
| Price on release | $0.690 |
| EPS estimate | -$0.0600 |
| EPS actual | $0.130 |
| EPS surprise | 316.67% |
| Date | Price |
|---|---|
| Mar 11, 2026 | $0.680 |
| Mar 12, 2026 | $0.695 |
| Mar 13, 2026 | $0.690 |
| Mar 16, 2026 | $0.701 |
| Mar 17, 2026 | $0.690 |
| Mar 18, 2026 | $0.700 |
| Mar 19, 2026 | $0.702 |
| Mar 20, 2026 | $0.687 |
| Mar 23, 2026 | $0.723 |
| 4 days before | 1.47% |
| 4 days after | 4.74% |
| On release day | 1.45% |
| Change in period | 6.28% |
Apr 30, 2026
(Upcoming)
| Release date | Jul 01, 2026 |
| Price on release | - |
| EPS estimate | -$0.0600 |
| EPS actual | - |
| Date | Price |
|---|---|
| May 27, 2026 | $0.760 |
| May 28, 2026 | $0.86 |
| May 29, 2026 | $0.83 |
| Jun 01, 2026 | $0.80 |
| Jun 02, 2026 | $0.751 |
Pharmacyt Biotch Earnings History
Earnings Calendar
FAQ
When is the earnings report for PMCB?
Pharmacyt Biotch (PMCB) has scheduled its earnings report for Jul 01, 2026 after the markets close.
What is the PMCB price-to-earnings (P/E) ratio?
PMCB P/E ratio as of Jun 02, 2026 (TTM) is -2.12.
What is the PMCB EPS forecast?
The forecasted EPS (Earnings Per Share) for Pharmacyt Biotch (PMCB) for the first fiscal quarter 2026 is -$0.0600.
What are Pharmacyt Biotch's retained earnings?
On its balance sheet, Pharmacyt Biotch reported retained earnings of $0 for the latest quarter ending Jan 31, 2026.
What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.
Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.
What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
